Literature DB >> 16126325

Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer.

Nicolas Barry Delongchamps1, Kaili Mao, Hang Theng, Marc Zerbib, Bernard Debré, Michaël Peyromaure.   

Abstract

OBJECTIVES: To analyze the outcome of patients after fortuitous diagnosis of prostate cancer (PCa) on cystoprostatectomy (CPT) specimen.
METHODS: The medical charts of 141 male patients who underwent radical CPT for urothelial cell carcinoma of the bladder between january 1995 and april 2000 were retrospectively reviewed. None of the patients had preoperative clinical or biological suspicion of PCa.
RESULTS: Pathological examination of the CPT specimens showed PCa in 20 patients (14.2%). Of these, 6 had a microfocal PCa, 10 had a pT2a tumour, 2 had a pT2b tumour, and 2 had a pT3a tumour. The Gleason score was < or =5 in 5 cases, 6 in 13 cases, and 7 in 2 cases. Two patients were lost to follow-up. Ten patients died of bladder cancer after a median follow-up of 13 months. Eight patients remained free of disease after a median follow-up of 64.5 months. None of the 20 patients experienced PCa recurrence during follow-up.
CONCLUSIONS: In our experience, the rate of unsuspected PCa on cystoprostatectomy specimens was 14.2%. The majority of these PCas were organ-confined, and there was no PCa recurrence during follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 16126325     DOI: 10.1016/j.eururo.2005.07.008

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

1.  The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens.

Authors:  M Alsinnawi; B Loftus; R Flynn; T McDermott; R Grainger; J A Thornhill
Journal:  Int Urol Nephrol       Date:  2012-07-07       Impact factor: 2.370

2.  Clinical Significance of Incidental Prostatic Carcinoma on Radical Cystectomy Histology Specimens: a Clinicopathological and Survival Analysis.

Authors:  Dharma Ram; Suhas K Rajappa; Sudhir Rawal; Amitabh Singh; Kailash Chand Sharma; Ajay Kumar Dewan
Journal:  Indian J Surg Oncol       Date:  2018-04-21

3.  Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.

Authors:  H M Fritsche; A Aziz; F Eder; W Otto; S Denzinger; W F Wieland; M May; F Hofstädter; A Hartmann; M Burger
Journal:  Virchows Arch       Date:  2012-10-09       Impact factor: 4.064

Review 4.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

5.  Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer.

Authors:  Toshifumi Kurahashi; Hideaki Miyake; Junya Furukawa; Masafumi Kumano; Atsushi Takenaka; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2009-05-16       Impact factor: 2.370

6.  Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens.

Authors:  Berna Aytac; Hakan Vuruskan
Journal:  World J Surg Oncol       Date:  2011-07-20       Impact factor: 2.754

7.  Oncologic aspects of long-term followed incidental prostate cancer detected by cystoprostatectomy in Korean patients.

Authors:  In-Chang Cho; Jeong Eun Kim; Sung Han Kim; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Weon Seo Park; Kang Hyun Lee
Journal:  Prostate Int       Date:  2015-04-07

8.  Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in Chinese patients.

Authors:  Jiahua Pan; Wei Xue; Jianjun Sha; Hu Yang; Fan Xu; Hanqing Xuan; Dong Li; Yiran Huang
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

9.  Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival.

Authors:  Joshua B Kaelberer; Michael A O'Donnell; Darrion L Mitchell; Anthony N Snow; Sarah L Mott; John M Buatti; Mark C Smith; John M Watkins
Journal:  Prostate Int       Date:  2016-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.